Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

Background: Cholinesterase inhibitors produce small improvements in cognitive and global assessments in Alzheimer's disease. We aimed to determine whether donepezil produces worthwhile improvements in disability, dependency, behavioural and psychological symptoms, carers' psychological wellbeing, or...

Full description

Bibliographic Details

Published in:	Lancet Vol. 363; no. 9427; pp. 2105 - 2116
Main Authors:	Courtney, C, Farrell, D, Gray, R, Hills, R, Lynch, L, Sellwood, E, Edwards, S, Hardyman, W, Raftery, J, Crome, P, Lendon, C, Shaw, H, Bentham, P
Format:	clinical trial research tables/charts Journal Article
Published:	Lancet 6/26/2004
Online Access:	View this record in EBSCOhost